Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China
Among persons born in China before 1980 and tested for vaccinia virus Tiantan strain (VVT), 28.7% (137/478) had neutralizing antibodies, 71.4% (25/35) had memory B-cell responses, and 65.7% (23/35) had memory T-cell responses to VVT. Because of cross-immunity between the viruses, these findings can...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2024-02-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/30/2/23-0542_article |
| _version_ | 1827375108579131392 |
|---|---|
| author | Yu Huang Li Guo Yanan Li Lili Ren Jiqin Nie Fengwen Xu Tingxuan Huang Jingchuan Zhong Zhangling Fan Yin Zhang Yu Xie Qiao Zhang Shan Mei Yan Xiao Xinming Wang Liuhui Xu Fei Guo Jianwei Wang |
| author_facet | Yu Huang Li Guo Yanan Li Lili Ren Jiqin Nie Fengwen Xu Tingxuan Huang Jingchuan Zhong Zhangling Fan Yin Zhang Yu Xie Qiao Zhang Shan Mei Yan Xiao Xinming Wang Liuhui Xu Fei Guo Jianwei Wang |
| author_sort | Yu Huang |
| collection | DOAJ |
| description |
Among persons born in China before 1980 and tested for vaccinia virus Tiantan strain (VVT), 28.7% (137/478) had neutralizing antibodies, 71.4% (25/35) had memory B-cell responses, and 65.7% (23/35) had memory T-cell responses to VVT. Because of cross-immunity between the viruses, these findings can help guide mpox vaccination strategies in China.
|
| first_indexed | 2024-03-08T11:46:00Z |
| format | Article |
| id | doaj.art-eeabc044e76c499ba28b430135f5c47b |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-03-08T11:46:00Z |
| publishDate | 2024-02-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-eeabc044e76c499ba28b430135f5c47b2024-01-24T22:09:43ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592024-02-0130232132410.3201/eid3002.230542Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, ChinaYu HuangLi GuoYanan LiLili RenJiqin NieFengwen XuTingxuan HuangJingchuan ZhongZhangling FanYin ZhangYu XieQiao ZhangShan MeiYan XiaoXinming WangLiuhui XuFei GuoJianwei Wang Among persons born in China before 1980 and tested for vaccinia virus Tiantan strain (VVT), 28.7% (137/478) had neutralizing antibodies, 71.4% (25/35) had memory B-cell responses, and 65.7% (23/35) had memory T-cell responses to VVT. Because of cross-immunity between the viruses, these findings can help guide mpox vaccination strategies in China. https://wwwnc.cdc.gov/eid/article/30/2/23-0542_articlevaccinia virussmallpoxmpoxmonkeypoxvirusesneutralizing antibodies |
| spellingShingle | Yu Huang Li Guo Yanan Li Lili Ren Jiqin Nie Fengwen Xu Tingxuan Huang Jingchuan Zhong Zhangling Fan Yin Zhang Yu Xie Qiao Zhang Shan Mei Yan Xiao Xinming Wang Liuhui Xu Fei Guo Jianwei Wang Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China Emerging Infectious Diseases vaccinia virus smallpox mpox monkeypox viruses neutralizing antibodies |
| title | Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China |
| title_full | Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China |
| title_fullStr | Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China |
| title_full_unstemmed | Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China |
| title_short | Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China |
| title_sort | residual immunity from smallpox vaccination and possible protection from mpox china |
| topic | vaccinia virus smallpox mpox monkeypox viruses neutralizing antibodies |
| url | https://wwwnc.cdc.gov/eid/article/30/2/23-0542_article |
| work_keys_str_mv | AT yuhuang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT liguo residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT yananli residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT liliren residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT jiqinnie residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT fengwenxu residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT tingxuanhuang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT jingchuanzhong residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT zhanglingfan residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT yinzhang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT yuxie residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT qiaozhang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT shanmei residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT yanxiao residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT xinmingwang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT liuhuixu residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT feiguo residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina AT jianweiwang residualimmunityfromsmallpoxvaccinationandpossibleprotectionfrommpoxchina |